Rheumatoid arthritis

A potential role for chlamydial infection in rheumatoid arthritis development

Rheumatology (Oxford)Published Nested case-control study within a prospective cohort

Authors' conclusion

Self-reported chlamydial infections are associated with elevated RA autoimmunity in at-risk individuals.

Study context

Population
First-degree relatives of rheumatoid arthritis (RA) patients (RA-FDR) in a prospective Swiss-based cohort who answered a questionnaire on past chlamydial infections
Participants
1,231 RA-FDRs
Comparison
Prior chlamydial infection in RA-FDRs with RA autoimmunity vs controls
  • RA autoimmunityn = 168
Outcome
RA autoimmunity (positivity for ACPA and/or RF)
Methodological detailsSwiss-based RA-FDR cohort, independent USA-based replication cohort
  • Swiss-based RA-FDR cohort
  • Independent USA-based replication cohort

Main finding

As reported in the abstract

Prevalence of self-reported chlamydial infection
RA autoimmunity vs ControlsEstimate (95% CI)P value
Prevalence of self-reported chlamydial infection
OR 2.00(1.27–3.09)
P < 0.01
Remained significant after adjustments
OR (adjusted) 1.91(1.20–2.95)
RA-FDRs who developed RA autoimmunity
168 (13.6%)

Observational data: associations, not effects.

Secondary outcomes

Positive C. trachomatis serology and high levels of RA autoimmunity

OR (95% CI)P value
Positive C. trachomatis serology3.05 (1.10–8.46)P = 0.032

Later stages of RA development

Stronger effect sizes were observed in later stages of RA development

Replication cohort (USA)

Significant associations between chlamydial infection and rheumatoid factor (RF) positivity and incident RA, but not anti-CCP positivity

Original publication

A potential role for chlamydial infection in rheumatoid arthritis development. Rheumatology (Oxford). Published 13 December 2023. doi:10.1093/rheumatology/kead682

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.